|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N119 |
398 |
$762,209.99 |
2.58% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
1,724 |
$761,301.16 |
2.58% |
| DexCom, Inc. |
DXCM |
252131107 |
1,353 |
$742,891.71 |
2.52% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
32,075 |
$743,860.10 |
2.52% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
1,870 |
$733,416.50 |
2.49% |
| PerkinElmer, Inc. |
PKI |
714046109 |
4,064 |
$717,499.20 |
2.43% |
| Terumo Corporation |
4543.JP |
J83173104 |
14,530 |
$718,254.72 |
2.43% |
| Hoya Corporation |
7741.JP |
J22848105 |
4,294 |
$713,990.63 |
2.42% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
6,079 |
$711,668.53 |
2.41% |
| ResMed Inc. |
RMD |
761152107 |
2,608 |
$705,464.00 |
2.39% |
| Danaher Corporation |
DHR |
235851102 |
2,222 |
$702,152.00 |
2.38% |
| Waters Corporation |
WAT |
941848103 |
1,804 |
$686,873.00 |
2.33% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,178 |
$684,911.99 |
2.32% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
666 |
$675,157.50 |
2.29% |
| Agilent Technologies, Inc. |
A |
00846U101 |
4,021 |
$669,013.98 |
2.27% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
1,177 |
$670,746.23 |
2.27% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
864 |
$662,256.00 |
2.24% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
9,658 |
$656,579.46 |
2.23% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
3,083 |
$651,096.72 |
2.21% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
1,098 |
$652,947.66 |
2.21% |
| Align Technology, Inc. |
ALGN |
016255101 |
892 |
$625,327.68 |
2.12% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
422 |
$623,699.12 |
2.11% |
| Alcon Inc. |
ALC.SW |
H01301128 |
7,315 |
$610,452.47 |
2.07% |
| Masimo Corporation |
MASI |
574795100 |
2,200 |
$606,518.00 |
2.06% |
| Boston Scientific Corporation |
BSX |
101137107 |
13,228 |
$588,116.88 |
1.99% |
| The Cooper Companies, Inc. |
COO |
216648402 |
1,354 |
$584,223.92 |
1.98% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
11,024 |
$579,179.22 |
1.96% |
| Stryker Corporation |
SYK |
863667101 |
2,105 |
$575,675.40 |
1.95% |
| Olympus Corporation |
7733.JP |
J61240107 |
25,440 |
$569,890.82 |
1.93% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
3,379 |
$557,824.94 |
1.89% |
| Steris Plc |
STE |
G8473T100 |
2,596 |
$558,191.92 |
1.89% |
| Medtronic Plc |
MDT |
G5960L103 |
4,298 |
$553,367.50 |
1.88% |
| ABIOMED, Inc. |
ABMD |
003654100 |
1,628 |
$551,029.16 |
1.87% |
| Abbott Laboratories |
ABT |
002824100 |
4,352 |
$524,764.16 |
1.78% |
| Hologic, Inc. |
HOLX |
436440101 |
7,059 |
$522,577.77 |
1.77% |
| Insulet Corporation |
PODD |
45784P101 |
1,822 |
$521,602.16 |
1.77% |
| Becton, Dickinson and Company |
BDX |
075887109 |
2,068 |
$519,957.24 |
1.76% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
22,629 |
$507,744.65 |
1.72% |
| Baxter International Inc. |
BAX |
071813109 |
6,252 |
$503,723.64 |
1.71% |
| DENTSPLY SIRONA Inc. |
XRAY |
24906P109 |
8,272 |
$502,358.56 |
1.70% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
27,098 |
$493,860.79 |
1.67% |
| Teleflex Incorporated |
TFX |
879369106 |
1,251 |
$484,412.22 |
1.64% |
| BioMerieux |
BIM.FP |
F1149Y109 |
4,073 |
$479,753.74 |
1.63% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
3,148 |
$477,047.92 |
1.62% |
| Guardant Health, Inc. |
GH |
40131M109 |
3,414 |
$429,208.08 |
1.45% |
| 10X Genomics, Inc. (Class A) |
TXG |
88025U109 |
2,788 |
$424,835.44 |
1.44% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
8,938 |
$405,697.69 |
1.38% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
4,161 |
$395,295.00 |
1.34% |
| NovoCure Limited |
NVCR |
G6674U108 |
2,811 |
$353,314.59 |
1.20% |
| Ambu A/S (Class B) |
AMBUB.DC |
K03293147 |
9,906 |
$333,456.66 |
1.13% |
| US Dollar |
$USD |
|
16,123 |
$16,123.31 |
0.05% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|